(Q41586629)

4 October 2017

1 reference

title

Bone marrow transplantation for pediatric malignancies (English)

1 reference

4 October 2017

J E Sanders

1

1 reference

4 October 2017

publication date

1 August 1997

1 reference

Pediatric Clinics of North America

4 October 2017

published in

1 reference

4 October 2017

volume

44

1 reference

4 October 2017

issue

4

1 reference

4 October 2017

page(s)

1005-1020

1 reference

Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation.

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Gene marking to improve the outcome of autologous bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Disturbances in dental development after total body irradiation in bone marrow transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Ocular Manifestations of Graft-v-Host Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

High-dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high-risk brain tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Fotemustine in the treatment of brain primary tumors and metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Growth and development in children after bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: a Childrens Cancer Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970542-3

10.1016/S0031-3955(05)70542-3

7 January 2021

Identifiers

DOI

1 reference

4 October 2017

1 reference